Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

A multicenter phase II study of temozolomide plus disulfiram and copper for recurrent temozolomide-resistant glioblastoma.

Huang J, Chaudhary R, Cohen AL, Fink K, Goldlust S, Boockvar J, Chinnaiyan P, Wan L, Marcus S, Campian JL.

J Neurooncol. 2019 May;142(3):537-544. doi: 10.1007/s11060-019-03125-y. Epub 2019 Feb 15.

PMID:
30771200
2.

Correction to: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.

Liau LM, Ashkan K, Tran DD, Campian JL, Trusheim JE, Cobbs CS, Heth JA, Salacz M, Taylor S, D'Andre SD, Iwamoto FM, Dropcho EJ, Moshel YA, Walter KA, Pillainayagam CP, Aiken R, Chaudhary R, Goldlust SA, Bota DA, Duic P, Grewal J, Elinzano H, Toms SA, Lillehei KO, Mikkelsen T, Walbert T, Abram SR, Brenner AJ, Brem S, Ewend MG, Khagi S, Portnow J, Kim LJ, Loudon WG, Thompson RC, Avigan DE, Fink KL, Geoffroy FJ, Lindhorst S, Lutzky J, Sloan AE, Schackert G, Krex D, Meisel HJ, Wu J, Davis RP, Duma C, Etame AB, Mathieu D, Kesari S, Piccioni D, Westphal M, Baskin DS, New PZ, Lacroix M, May SA, Pluard TJ, Tse V, Green RM, Villano JL, Pearlman M, Petrecca K, Schulder M, Taylor LP, Maida AE, Prins RM, Cloughesy TF, Mulholland P, Bosch ML.

J Transl Med. 2018 Jun 29;16(1):179. doi: 10.1186/s12967-018-1552-1.

3.

The decline of malaria in Vietnam, 1991-2014.

Goldlust SM, Thuan PD, Giang DDH, Thang ND, Thwaites GE, Farrar J, Thanh NV, Nguyen TD, Grenfell BT, Boni MF, Hien TT.

Malar J. 2018 Jun 7;17(1):226. doi: 10.1186/s12936-018-2372-8.

4.

First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.

Liau LM, Ashkan K, Tran DD, Campian JL, Trusheim JE, Cobbs CS, Heth JA, Salacz M, Taylor S, D'Andre SD, Iwamoto FM, Dropcho EJ, Moshel YA, Walter KA, Pillainayagam CP, Aiken R, Chaudhary R, Goldlust SA, Bota DA, Duic P, Grewal J, Elinzano H, Toms SA, Lillehei KO, Mikkelsen T, Walbert T, Abram SR, Brenner AJ, Brem S, Ewend MG, Khagi S, Portnow J, Kim LJ, Loudon WG, Thompson RC, Avigan DE, Fink KL, Geoffroy FJ, Lindhorst S, Lutzky J, Sloan AE, Schackert G, Krex D, Meisel HJ, Wu J, Davis RP, Duma C, Etame AB, Mathieu D, Kesari S, Piccioni D, Westphal M, Baskin DS, New PZ, Lacroix M, May SA, Pluard TJ, Tse V, Green RM, Villano JL, Pearlman M, Petrecca K, Schulder M, Taylor LP, Maida AE, Prins RM, Cloughesy TF, Mulholland P, Bosch ML.

J Transl Med. 2018 May 29;16(1):142. doi: 10.1186/s12967-018-1507-6. Erratum in: J Transl Med. 2018 Jun 29;16(1):179.

5.

Deploying digital health data to optimize influenza surveillance at national and local scales.

Lee EC, Arab A, Goldlust SM, Viboud C, Grenfell BT, Bansal S.

PLoS Comput Biol. 2018 Mar 7;14(3):e1006020. doi: 10.1371/journal.pcbi.1006020. eCollection 2018 Mar.

6.

Go, no-go decision making for phase 3 clinical trials: ACT IV revisited - Authors' reply.

Weller M, Butowski N, Tran DD, Recht LD, Lim M, Hirte H, Ashby L, Mechtler L, Goldlust SA, Iwamoto F, Drappatz J, O'Rourke DM, Wong M, Hamilton MG, Finocchiaro G, Perry J, Wick W, Green J, He Y, Turner CD, Yellin MJ, Keler T, Davis TA, Stupp R, Sampson JH.

Lancet Oncol. 2017 Dec;18(12):e709-e710. doi: 10.1016/S1470-2045(17)30856-2. No abstract available.

PMID:
29208433
7.

Decreasing Emergency Department Walkout Rate and Boarding Hours by Improving Inpatient Length of Stay.

Artenstein AW, Rathlev NK, Neal D, Townsend V, Vemula M, Goldlust S, Schmidt J, Visintainer P.

West J Emerg Med. 2017 Oct;18(6):982-992. doi: 10.5811/westjem.2017.7.34663. Epub 2017 Sep 18.

8.

Health-related quality of life, cognitive screening, and functional status in a randomized phase III trial (EF-14) of tumor treating fields with temozolomide compared to temozolomide alone in newly diagnosed glioblastoma.

Zhu JJ, Demireva P, Kanner AA, Pannullo S, Mehdorn M, Avgeropoulos N, Salmaggi A, Silvani A, Goldlust S, David C, Benouaich-Amiel A; Zvi Ram on behalf of the EF-14 Trial Investigators.

J Neurooncol. 2017 Dec;135(3):545-552. doi: 10.1007/s11060-017-2601-y. Epub 2017 Aug 28.

9.

Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial.

Weller M, Butowski N, Tran DD, Recht LD, Lim M, Hirte H, Ashby L, Mechtler L, Goldlust SA, Iwamoto F, Drappatz J, O'Rourke DM, Wong M, Hamilton MG, Finocchiaro G, Perry J, Wick W, Green J, He Y, Turner CD, Yellin MJ, Keler T, Davis TA, Stupp R, Sampson JH; ACT IV trial investigators.

Lancet Oncol. 2017 Oct;18(10):1373-1385. doi: 10.1016/S1470-2045(17)30517-X. Epub 2017 Aug 23.

10.

Mind the Scales: Harnessing Spatial Big Data for Infectious Disease Surveillance and Inference.

Lee EC, Asher JM, Goldlust S, Kraemer JD, Lawson AB, Bansal S.

J Infect Dis. 2016 Dec 1;214(suppl_4):S409-S413. doi: 10.1093/infdis/jiw344. Review.

11.

Seizure prophylaxis and melanoma brain metastases.

Goldlust SA, Hsu M, Lassman AB, Panageas KS, Avila EK.

J Neurooncol. 2012 May;108(1):109-14. doi: 10.1007/s11060-012-0802-y. Epub 2012 Feb 5.

PMID:
22311106
12.

Bevacizumab for glioblastoma refractory to vascular endothelial growth factor receptor inhibitors.

Goldlust SA, Cavaliere R, Newton HB, Hsu M, Deangelis LM, Batchelor TT, Gilbert MR, Lassman AB.

J Neurooncol. 2012 Apr;107(2):407-11. doi: 10.1007/s11060-011-0768-1. Epub 2011 Dec 28.

PMID:
22203237
13.

Intracranial hemorrhage in patients with cancer treated with bevacizumab: the Memorial Sloan-Kettering experience.

Khasraw M, Holodny A, Goldlust SA, DeAngelis LM.

Ann Oncol. 2012 Feb;23(2):458-63. doi: 10.1093/annonc/mdr148. Epub 2011 May 4.

PMID:
21543627
14.

Headache in patients with cancer.

Goldlust SA, Graber JJ, Bossert DF, Avila EK.

Curr Pain Headache Rep. 2010 Dec;14(6):455-64. doi: 10.1007/s11916-010-0153-3. Review.

PMID:
20927609
15.

Retrospective analysis of the efficacy and tolerability of levetiracetam in patients with metastatic brain tumors.

Newton HB, Dalton J, Goldlust S, Pearl D.

J Neurooncol. 2007 Sep;84(3):293-6. Epub 2007 Apr 13.

PMID:
17431542
16.

Retrospective analysis of the efficacy and tolerability of levetiracetam in brain tumor patients.

Newton HB, Goldlust SA, Pearl D.

J Neurooncol. 2006 May;78(1):99-102. Epub 2006 Mar 16.

PMID:
16541329
17.

Epidermal growth factor receptor antagonists: novel therapy for the treatment of high-grade gliomas.

Nathoo N, Goldlust S, Vogelbaum MA.

Neurosurgery. 2004 Jun;54(6):1480-8; discussion 1488-9. Review.

PMID:
15157306
18.

Randomized prospective comparison of forced air warming using hospital blankets versus commercial blankets in surgical patients.

Kabbara A, Goldlust SA, Smith CE, Hagen JF, Pinchak AC.

Anesthesiology. 2002 Aug;97(2):338-44.

PMID:
12151922

Supplemental Content

Loading ...
Support Center